BRIAN M POSNER
CIK 1287711 · Chief Financial Officer · last filed 2025-10-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$136.6K
Companies
6
Total Filings
58
Lifetime Open-Market Net
$104.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AIFF | Director | — | $1.10 | — | $0 | 2 | 2025-10-30 |
| ECOR | Chief Financial Officer | 22,437 | $6.09 | $136.6K | $28.4K | 10 | 2024-01-17 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Chief Financial Officer | — | $0.12 | — | $0 | 3 | 2019-01-18 |
| Alliqua BioMedical, Inc. (ALQA) Delisted | Chief Financial Officer | 79,404 | — | — | $48.5K | 12 | 2017-09-25 |
| OPTT | Chief Financial Officer | 47 | $0.15 | $7 | $18.2K | 8 | 2013-07-17 |
| PHARMACOPEIA INC (PCOP) Delisted | EVP, CFO | 0 | — | — | $8.9K | 21 | 2008-12-24 |
Recent Filings · Page 3 of 6
58 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-11-10 | Alliqua BioMedical, Inc. (ALQA) Delisted | Buy (P) | +5,000 | $15.2K | EDGAR |
| 2015-08-10 | Alliqua BioMedical, Inc. (ALQA) Delisted | Buy (P) | +2,500 | $12.5K | EDGAR |
| 2015-05-20 | Alliqua BioMedical, Inc. (ALQA) Delisted | Buy (P) | +2,500 | $10.8K | EDGAR |
| 2015-03-10 | Alliqua BioMedical, Inc. (ALQA) Delisted | Tax (F) | −759 | -$4.0K | EDGAR |
| 2015-02-09 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2014-09-16 | Alliqua BioMedical, Inc. (ALQA) Delisted | Buy (P) | +2,000 | $9.9K | EDGAR |
| 2014-03-10 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | +2,640 | $0 | EDGAR |
| 2013-09-05 | — | Grant (A) | — | $0 | |
| 2013-07-17 | OPTT | Mixed | −2,194 | -$758 | EDGAR |
| 2013-06-28 | OPTT | Mixed | −515 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.